Hyunsun Jo
Founder & Chief Executive Officer Pin Therapeutics
Seminars
Wednesday 28th October 2026
Fireside Chat: Translating Early Clinical Signals into Strategies for Maximizing Efficacy & Safety of Induced Proximity Therapeutics
2:15 pm
- Translating PKPD from preclinical models to patients to predict target engagement and advance investigational induced proximity molecules into first-in-human studies
- Integrating reverse translation and learnings from unexpected clinical readouts to inform clinical strategy
- Demonstrating safety and efficacy of induced proximity clinical candidates
Tuesday 27th October 2026
A Novel TPD Platform Leveraging a New E3 Ligase to Minimize Hematologic Toxicity
12:30 pm
- Introduction of a novel TPD platform with a differentiated profile based on a new E3 ligase
- Data highlighting efficient target degradation with reduced hematologic off-target effects
- Insights into strategies to mitigate toxicity risk in future TPD development
